Clinical Trial Update: Long-Term Safety and Tolerability of Idebenone in Friedreich's Ataxia Patients (MICONOS Extension) [Phase 3]

View source ↗

Summary

The document reports long-term safety and tolerability data from the Phase 3 extension study (MICONOS Extension) of idebenone in Friedreich's ataxia, with resul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Friedreich Ataxia

Drugs mentioned

• Idebenone (idebenone)

Snippet

Sponsor: Santhera Pharmaceuticals | Conditions: Freidreich's Ataxia | Phase 3 | Status: COMPLETED | Results posted: 2018-03-05